Literature DB >> 1706637

Suppressive effect of E-64c on ischemic degradation of cerebral proteins following occlusion of the middle cerebral artery in rats.

T Inuzuka1, A Tamura, S Sato, T Kirino, I Toyoshima, T Miyatake.   

Abstract

Microtubule-associated protein 2 (MAP2) levels in the left cerebral hemisphere decreased significantly 3 days after occlusion of the left middle cerebral artery in rats to 29 +/- 16.3% of control levels. Since MAP2 is one of the substrates of calpain, E-64c, a synthetic calpain inhibitor, was administered at a dose of 400 mg/kg twice a day for 3 days, with the first dose being given before the production of ischemia. This depletion was significantly inhibited in vivo by E-64c (P less than 0.05) to increase MAP2 levels to 55 +/- 25.7% of control levels. E-64c had no significant effect on the ischemia-induced depletion of myelin-associated glycoprotein. Sham-operated rats were used as controls. Our results suggest that calpain is partially involved in the degradation of MAP2, and that the use of calpain inhibitors can be a useful clinical approach to cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1706637     DOI: 10.1016/0006-8993(90)90269-h

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

Review 1.  Calpain and synaptic function.

Authors:  Hai-Yan Wu; David R Lynch
Journal:  Mol Neurobiol       Date:  2006-06       Impact factor: 5.590

2.  Role of calpain in spinal cord injury: increased calpain immunoreactivity in rat spinal cord after impact trauma.

Authors:  Z Li; E L Hogan; N L Banik
Journal:  Neurochem Res       Date:  1996-04       Impact factor: 3.996

3.  The cysteine protease inhibitor, E64d, reduces brain amyloid-β and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, β-secretase activity.

Authors:  Gregory Hook; Vivian Hook; Mark Kindy
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

4.  Damage-induced neuronal endopeptidase (DINE) is a unique metallopeptidase expressed in response to neuronal damage and activates superoxide scavengers.

Authors:  S Kiryu-Seo; M Sasaki; H Yokohama; S Nakagomi; T Hirayama; S Aoki; K Wada; H Kiyama
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

Review 5.  Cathepsin B Gene Knockout Improves Behavioral Deficits and Reduces Pathology in Models of Neurologic Disorders.

Authors:  Gregory Hook; Thomas Reinheckel; Junjun Ni; Zhou Wu; Mark Kindy; Christoph Peters; Vivian Hook
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

6.  Temperature effect on immunostaining of microtubule-associated protein 2 and synaptophysin after 30 minutes of forebrain ischemia in rat.

Authors:  T Miyazawa; P Bonnekoh; K A Hossmann
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

7.  Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat.

Authors:  K E Saatman; H Murai; R T Bartus; D H Smith; N J Hayward; B R Perri; T K McIntosh
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

Review 8.  Cathepsin B in neurodegeneration of Alzheimer's disease, traumatic brain injury, and related brain disorders.

Authors:  Vivian Hook; Michael Yoon; Charles Mosier; Gen Ito; Sonia Podvin; Brian P Head; Robert Rissman; Anthony J O'Donoghue; Gregory Hook
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2020-04-17       Impact factor: 3.036

Review 9.  Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate.

Authors:  Gregory Hook; J Steven Jacobsen; Kenneth Grabstein; Mark Kindy; Vivian Hook
Journal:  Front Neurol       Date:  2015-09-02       Impact factor: 4.003

10.  Use of recombinant factor VIIa (rFVIIa) as pre-hospital treatment in a swine model of fluid percussion traumatic brain injury.

Authors:  Bobby Kim; Ashraful Haque; Françoise G Arnaud; Kohsuke Teranishi; Thomas Steinbach; Charles R Auker; Richard M McCarron; Daniel Freilich; Anke H Scultetus
Journal:  J Emerg Trauma Shock       Date:  2014-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.